posted on 2021-08-25, 17:39authored byJelle van Schooten, Marlies M. van Haaren, Hui Li, Laura E. McCoy, Colin Havenar-Daughton, Christopher A. Cottrell, Judith A. Burger, Patricia van der Woude, Leanne C. Helgers, Ilhan Tomris, Celia C. Labranche, David C. Montefiori, Andrew B. Ward, Dennis R. Burton, John P. Moore, Rogier W. Sanders, Shane Crotty, George M. Shaw, Marit J. van Gils
For the immunized NHPs, BG505-specific B cells were selected by fluorescence activated cell sorting using two differently labeled BG505 SOSIPs. The gating strategy of NHP ROp15 is shown here (left). In contrast, BG505-specific B cells from the BG505 SHIV-infected NHPs were sorted with a BG505 SOSIP and BG505 SOSIP S241N trimer. The gating strategy of NHP 6454 is shown here (right).